-
Gan To Kagaku Ryoho · Feb 2007
[Participation in the international multi-countries study-operational issues from company view point].
- Shuji Hada.
- AstraZeneca KK, Research and Development, Clinical Division, Clinical Leaders Department Group 1.
- Gan To Kagaku Ryoho. 2007 Feb 1; 34 (2): 324-7.
AbstractAstraZeneca KK has participated in 6 international clinical studies in the development of anticancer agents. Having learned from the experiences, we would like to present operational issues of conducting the international studies in the development of anticancer agents from the standpoint of a pharmaceutical company. Also,we would like to show you differences in Japan from Western and other Asian countries, some aspects that we have to improve or make more efforts, and proposals for the future development to provide patients with good products simultaneously worldwide.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..